Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection

Genes and Immunity

Volumn 10, Issue 4, 2009, Pages 365-372

  Yee, L J ^a   Im, K ^a   Borg, B ^b   Yang, H ^c   Liang, T J ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PEGINTERFERON ALPHA2A;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ALLELES; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYETHYLENE GLYCOLS; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS C VIRUS;

EID: 67349284651     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.26     Document Type: Article

References (19)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.
2. Brown RS. Hepatitis C and liver transplantation. Nature 2005; 436: 973-978.
3. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36: S237-S244.
4. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001; 358: 958-965.
5. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N et al Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131: 470-477.
6. Jeffers LJ, Cassidy W, Howell CD, Hu S, Reddy KR. Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology 2004; 39: 1702-1708.
7. Muir AJ, Bornstein, JD, Killenberg PG. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004; 350: 2265-2271.
8. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999; 19: 141-155.
9. Huang Y, Feld JJ, Sapp RK, Nanda S, Lin JH, Blatt LM et al. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology 2007; 132: 733-744.
10. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
11. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
12. Nattermann J, Vogel M, Berg T, Danta M, Axel B, Mayr C et al. Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatology 2007; 46: 1016-1025.
13. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
14. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-706.
15. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N. Peg interferon and ribavirin treatment in African Americans and Caucasian American patients with chronic hepatitis C genotype I. J Gastroenterology 2006; 131: 470-477.
16. Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A et al. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology 2007; 46: 74-83.
17. Mathias RA, Gao P, Goldstein JL, Wilson AF, Pugh EW, Furbert-Harris P et al. A graphical assessment of P-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q BMC. Genetics 2006; 7: 38.
18. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945-959.
19. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. Association mapping in structured populations. Am J Hum Genet 2000; 67: 170-781.